BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines non-GAAP Adjusted Diluted Earnings (Loss) per ADS ($/ADS) ($)
Form 8-K EX-99.1 Non-GAAP Reconciliation Tables
Latest, FY2025
8.09
Period ended Dec 31, 2025
Change on a year earlier
-1,655.8%
-0.52 in FY2024
History
2 years
Since FY2024
Sources
1
Form 8-K (filed 2026-02-26)
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Adjusted Diluted Earnings (Loss) per ADS ($/ADS) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.09 | -1,655.8% | Form 8-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | -0.52 | – | Form 8-K (filed 2026-02-26) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Non-GAAP Adjusted Diluted Earnings (Loss) per ADS ($/ADS) ($), annual FY2024–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/adj_eps_ads_diluted
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.